On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2023 earnings per share (EPS) of -$0.05, up 66.67% year over year. Total Icad earnings for the quarter were -$1.37 million. In the same quarter last year, Icad's earnings per share (EPS) was -$0.15.
As of Q4 2023, Icad's earnings has grown year over year. Icad's earnings in the past year totalled -$10.00 million.
What was ICAD's revenue last quarter?
On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2023 revenue of $4.07 million up 6.56% year over year. In the same quarter last year, Icad's revenue was $4.36 million.
What was ICAD's revenue growth in the past year?
As of Q4 2023, Icad's revenue has grown -18.55% year over year. This is 25.15 percentage points lower than the US Medical Devices industry revenue growth rate of 6.6%. Icad's revenue in the past year totalled $22.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.